Skip to main content

Trilogy Capital Inc.

Position in JNJ — Johnson & Johnson

CIK 1722512 IRVINE, CA

Position in JNJ

as of Jun 30, 2026 · filed Jul 6, 2026
Position Value
$1,297,532
+$49,666 QoQ
Shares Held
5,109
+0.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#2,743
of 4,676 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in JNJ Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Trilogy Capital Inc. holds $25,279,882 across 7 Drug Manufacturers - General names. JNJ ranks #5 (5.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 JNJ
Johnson & Johnson
This page
5,109 $1,297,532

All Filings in JNJ

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,297,532 5,109
2026-03-31 $1,247,866 5,105
2025-12-31 $1,106,354 5,346
2025-09-30 $1,057,821 5,705
2025-06-30 $859,066 5,624
2025-03-31 $870,991 5,252
2024-12-31 $721,509 4,989
2024-09-30 $833,636 5,144
2024-06-30 $723,345 4,949
2024-03-31 $694,770 4,392
2023-12-31 $359,404 2,293
2023-09-30 $361,651 2,322
2023-06-30 $487,787 2,947
2023-03-31 $356,965 2,303
2022-12-31 $434,559 2,460
2022-09-30 $287,023 1,757
2022-06-30 $267,330 1,506
2022-03-31 $281,795 1,590
2021-12-31 $282,265 1,650
2021-09-30 $245,641 1,521
2021-06-30 $251,887 1,529
2021-03-31 $206,423 1,256